PRESS RELEASE PR Newswire
Apr. 13, 2022, 06:00 AM
Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Switzerland
GAITHERSBURG, Md., April 13, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and...